# MORGAN JESS S & CO INC

> Institutional holdings reported to the SEC as of Q3 2022 on Form 13F. CIK 1133335. Source: https://holderbook.com/funds/1133335-morgan-jess-s-co-inc/

- Reported value: $114.9M
- Positions: 36
- Weight of the ten largest: 47.0%
- Filed: 2022-10-21

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| PROSHARES TR | [SPXUXXXX](https://holderbook.com/stocks/SPXUXXXX/) | $12.1M | 539,276 | 10.5% | 1 |
| INVESCO QQQ TR | [QQQ](https://holderbook.com/stocks/QQQ/) | $5.5M | 20,430 | 4.8% | 12 |
| PROSHARES TR | [SQQQPS](https://holderbook.com/stocks/SQQQPS/) | $5.2M | 84,946 | 4.5% | 1 |
| INVESCO DB COMMDY INDX TRCK | [DBC](https://holderbook.com/stocks/DBC/) | $4.9M | 205,426 | 4.3% | 2 |
| UNITEDHEALTH GROUP INC | [UNH](https://holderbook.com/stocks/UNH/) | $4.8M | 9,416 | 4.1% | 12 |
| FIRST TR EXCHANGE TRAD FD VI | [FTGC](https://holderbook.com/stocks/FTGC/) | $4.6M | 180,899 | 4.0% | 3 |
| APPLE INC | [AAPL](https://holderbook.com/stocks/AAPL/) | $4.6M | 32,968 | 4.0% | 12 |
| PEPSICO INC | [PEP](https://holderbook.com/stocks/PEP/) | $4.3M | 26,408 | 3.8% | 12 |
| JOHNSON & JOHNSON | [JNJ](https://holderbook.com/stocks/JNJ/) | $4.1M | 25,327 | 3.6% | 12 |
| SPDR SERIES TRUST | [XBI](https://holderbook.com/stocks/XBI/) | $4.0M | 50,523 | 3.5% | 12 |
| NOVOCURE LTD | [NVCR](https://holderbook.com/stocks/NVCR/) | $3.7M | 49,090 | 3.2% | 12 |
| SELECT SECTOR SPDR TR | [XLP](https://holderbook.com/stocks/XLP/) | $3.7M | 55,844 | 3.2% | 12 |
| INTUIT | [INTU](https://holderbook.com/stocks/INTU/) | $3.7M | 9,508 | 3.2% | 12 |
| BROADCOM INC | [AVGO](https://holderbook.com/stocks/AVGO/) | $3.7M | 8,261 | 3.2% | 3 |
| AXSOME THERAPEUTICS INC | [AXSM](https://holderbook.com/stocks/AXSM/) | $3.5M | 78,895 | 3.1% | 12 |
| THERMO FISHER SCIENTIFIC INC | [TMO](https://holderbook.com/stocks/TMO/) | $3.5M | 6,850 | 3.0% | 11 |
| ISHARES TR | [IYJ](https://holderbook.com/stocks/IYJ/) | $3.4M | 40,264 | 2.9% | 12 |
| VANGUARD WORLD FD | [VCR](https://holderbook.com/stocks/VCR/) | $3.4M | 14,343 | 2.9% | 12 |
| ISHARES TR | [IEO](https://holderbook.com/stocks/IEO/) | $3.3M | 39,190 | 2.8% | 2 |
| HONEYWELL INTL INC | [HONZZZZ](https://holderbook.com/stocks/HONZZZZ/) | $3.3M | 19,483 | 2.8% | 12 |
| ISHARES TR | [SOXX](https://holderbook.com/stocks/SOXX/) | $3.1M | 9,637 | 2.7% | 12 |
| INVESCO EXCHANGE TRADED FD T | [PPA](https://holderbook.com/stocks/PPA/) | $2.8M | 43,979 | 2.5% | 2 |
| AGENUS INC | [AGEN](https://holderbook.com/stocks/AGEN/) | $2.7M | 1,302,030 | 2.3% | 7 |
| FIRST TR EXCHANGE-TRADED FD | [FDN](https://holderbook.com/stocks/FDN/) | $2.6M | 20,416 | 2.2% | 12 |
| ORAMED PHARMACEUTICALS INC | [ORMP](https://holderbook.com/stocks/ORMP/) | $2.4M | 366,401 | 2.1% | 12 |
| ISHARES TR | [IWV](https://holderbook.com/stocks/IWV/) | $2.0M | 9,679 | 1.7% | 12 |
| CHECKPOINT THERAPEUTICS INC | [CKPT](https://holderbook.com/stocks/CKPT/) | $2.0M | 1,894,694 | 1.7% | 7 |
| SELECT SECTOR SPDR TR | [XLK](https://holderbook.com/stocks/XLK/) | $1.8M | 15,402 | 1.6% | 12 |
| SELECT SECTOR SPDR TR | [XLV](https://holderbook.com/stocks/XLV/) | $1.4M | 11,761 | 1.2% | 12 |
| NUVEEN NASDAQ 100 DYNAMIC OV | [QQQX](https://holderbook.com/stocks/QQQX/) | $1.1M | 53,432 | 1.0% | 8 |
| VANGUARD INDEX FDS | [VTI](https://holderbook.com/stocks/VTI/) | $1.0M | 5,845 | 0.9% | 8 |
| ISHARES TR | [IGV](https://holderbook.com/stocks/IGV/) | $933.0K | 3,731 | 0.8% | 12 |
| MICROSOFT CORP | [MSFT](https://holderbook.com/stocks/MSFT/) | $748.0K | 3,212 | 0.7% | 4 |
| NVIDIA CORPORATION | [NVDA](https://holderbook.com/stocks/NVDA/) | $744.0K | 6,132 | 0.6% | 4 |
| CLENE INC | [CLNN](https://holderbook.com/stocks/CLNN/) | $314.0K | 112,000 | 0.3% | 5 |
| DIREXION SHS ETF TR | [LABUXXXX](https://holderbook.com/stocks/LABUXXXX/) | $200.0K | 28,500 | 0.2% | 2 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q3 2022 | -2.2% | -5.3% | +3.1% | 100% |
| Q2 2022 | -19.3% | -16.5% | -2.9% | 100% |
| Q1 2022 | -9.7% | -4.9% | -4.8% | 100% |
| Q4 2021 | +2.5% | +10.7% | -8.2% | 100% |
| Q3 2021 | -2.0% | +0.3% | -2.3% | 100% |
| Q2 2021 | +9.4% | +8.0% | +1.3% | 100% |
| Q1 2021 | +8.0% | +6.0% | +2.0% | 100% |
| Q4 2020 | +17.1% | +11.6% | +5.4% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q3 2022 | $114.9M | 36 |
| Q2 2022 | $96.4M | 37 |
| Q1 2022 | $137.5M | 43 |
| Q4 2021 | $162.9M | 46 |
| Q3 2021 | $151.5M | 41 |
| Q2 2021 | $152.2M | 40 |
| Q1 2021 | $142.7M | 44 |
| Q4 2020 | $125.6M | 40 |
| Q3 2020 | $100.2M | 40 |
| Q2 2020 | $92.1M | 40 |
| Q1 2020 | $76.9M | 38 |
| Q4 2019 | $101.9M | 43 |